News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

Articles by Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer

ByThomas E. Delea, MSIA,Jonathan Karnon, MSc, PhD,Robert E. Smith, MD,Stephen R. D. Johnston, MD, PhD, FRCP,Jane Brandman, BPharm, MS,Jennifer C. Y. Sung, PharmD,Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

July 15th 2006

Latest Updated Articles

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer
Published: July 15th 2006 | Updated:

Trending on AJMC

House Republicans Block Vote on ACA Subsidy Extension

5 Things to Know as Flu Season Begins

Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL

Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis

FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.